GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Price-to-Free-Cash-Flow

Clearmind Medicine (Clearmind Medicine) Price-to-Free-Cash-Flow : N/A (As of Jun. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Price-to-Free-Cash-Flow?

As of today (2024-06-18), Clearmind Medicine's share price is $1.23. Clearmind Medicine's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $-5.98. Hence, Clearmind Medicine's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Clearmind Medicine's Price-to-Free-Cash-Flow or its related term are showing as below:

CMND's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.825
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Clearmind Medicine's Free Cash Flow per Share for the three months ended in Jan. 2024 was $-0.96. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-5.98.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -25.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -37.20% per year.

During the past 7 years, Clearmind Medicine's highest 3-Year average Free Cash Flow per Share Growth Rate was -25.20% per year. The lowest was -139.00% per year. And the median was -52.90% per year.


Clearmind Medicine Price-to-Free-Cash-Flow Historical Data

The historical data trend for Clearmind Medicine's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Price-to-Free-Cash-Flow Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Clearmind Medicine's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Clearmind Medicine's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Price-to-Free-Cash-Flow falls into.



Clearmind Medicine Price-to-Free-Cash-Flow Calculation

Clearmind Medicine's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.23/-5.983
=N/A

Clearmind Medicine's Share Price of today is $1.23.
Clearmind Medicine's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.98.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Clearmind Medicine  (NAS:CMND) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Clearmind Medicine Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (Clearmind Medicine) Headlines

From GuruFocus